HSV and varicella zoster virus ... Although molecular assays detect HSV1/2 and VZV more quickly, the clinical significance of positive results may vary in individual patients.
As a result of the termination of its lease, the Company expects savings of approximately $2.0 million of cash expenses ...
Mustang Bio, Inc. ("Mustang" or the "Company") (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs ...
3d
News Medical on MSNScientists uncover how herpes virus fuels Alzheimer’s diseaseHerpesvirus infection may contribute to Alzheimer’s disease through transposable element activation and neuroinflammation.
4d
News-Medical.Net on MSNNew target identified for preventing cold sores and genital herpesScientists have a new target to prevent cold sores after University of Virginia School of Medicine researchers discovered an unexpected way the herpes virus re-activates in the body.
Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of ...
2d
Study Finds on MSNThe surprising way herpes virus hijacks one’s immune system to reactivateIn a nutshell Scientists discovered that the herpes virus protein UL12.5 hijacks the body’s own immune pathways to trigger ...
The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...
Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA’s) announcement that its Committee for Medicinal ...
Krystal Biotech, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive recommendation for VYJUVEK® (beremagene geperpavec-svdt ...
Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA's) announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results